Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 18 studies | 35% ± 16% | |
| peripheral blood | 12 studies | 24% ± 5% | |
| intestine | 12 studies | 31% ± 16% | |
| kidney | 9 studies | 27% ± 7% | |
| brain | 9 studies | 27% ± 10% | |
| eye | 6 studies | 28% ± 11% | |
| liver | 6 studies | 27% ± 19% | |
| placenta | 5 studies | 44% ± 23% | |
| uterus | 5 studies | 44% ± 14% | |
| pancreas | 4 studies | 57% ± 23% | |
| bone marrow | 4 studies | 22% ± 8% | |
| prostate | 4 studies | 46% ± 14% | |
| breast | 4 studies | 44% ± 4% | |
| heart | 3 studies | 21% ± 6% | |
| esophagus | 3 studies | 44% ± 26% | |
| skin | 3 studies | 39% ± 5% | |
| thymus | 3 studies | 36% ± 9% | |
| lymph node | 3 studies | 25% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6642.52 | 1445 / 1445 | 100% | 221.54 | 183 / 183 |
| lung | 100% | 9884.82 | 578 / 578 | 100% | 297.13 | 1155 / 1155 |
| ovary | 100% | 8022.08 | 180 / 180 | 100% | 303.71 | 430 / 430 |
| pancreas | 100% | 6208.42 | 328 / 328 | 100% | 317.82 | 178 / 178 |
| breast | 100% | 7766.31 | 459 / 459 | 100% | 374.93 | 1115 / 1118 |
| stomach | 100% | 6610.15 | 359 / 359 | 100% | 279.27 | 285 / 286 |
| skin | 100% | 9896.19 | 1806 / 1809 | 100% | 314.85 | 471 / 472 |
| intestine | 100% | 7239.61 | 966 / 966 | 100% | 287.69 | 525 / 527 |
| prostate | 100% | 7485.36 | 244 / 245 | 100% | 345.54 | 501 / 502 |
| uterus | 100% | 7425.64 | 170 / 170 | 99% | 268.88 | 456 / 459 |
| thymus | 100% | 8124.76 | 653 / 653 | 99% | 224.08 | 599 / 605 |
| bladder | 100% | 7752.76 | 21 / 21 | 99% | 264.17 | 499 / 504 |
| liver | 100% | 6634.89 | 226 / 226 | 99% | 172.11 | 401 / 406 |
| brain | 99% | 4168.32 | 2607 / 2642 | 100% | 223.55 | 705 / 705 |
| adrenal gland | 100% | 11746.49 | 258 / 258 | 98% | 217.76 | 226 / 230 |
| kidney | 100% | 6041.22 | 89 / 89 | 98% | 158.71 | 879 / 901 |
| adipose | 100% | 8983.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 132.14 | 29 / 29 |
| spleen | 100% | 5002.16 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 176.74 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 119.48 | 1 / 1 |
| blood vessel | 100% | 9829.23 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 98% | 2768.07 | 788 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 112.03 | 78 / 80 |
| heart | 97% | 5154.40 | 838 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 4662.01 | 895 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0060271 | Biological process | cilium assembly |
| GO_0061512 | Biological process | protein localization to cilium |
| GO_2000377 | Biological process | regulation of reactive oxygen species metabolic process |
| GO_0006890 | Biological process | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
| GO_0007612 | Biological process | learning |
| GO_0006886 | Biological process | intracellular protein transport |
| GO_0045176 | Biological process | apical protein localization |
| GO_1902017 | Biological process | regulation of cilium assembly |
| GO_0045197 | Biological process | establishment or maintenance of epithelial cell apical/basal polarity |
| GO_0016192 | Biological process | vesicle-mediated transport |
| GO_0060996 | Biological process | dendritic spine development |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
| GO_0016477 | Biological process | cell migration |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0099175 | Biological process | regulation of postsynapse organization |
| GO_0032587 | Cellular component | ruffle membrane |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0043197 | Cellular component | dendritic spine |
| GO_0016020 | Cellular component | membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
| GO_0106274 | Molecular function | NAD+-protein-arginine ADP-ribosyltransferase activity |
| GO_0005154 | Molecular function | epidermal growth factor receptor binding |
| GO_0005525 | Molecular function | GTP binding |
| GO_0005515 | Molecular function | protein binding |
| GO_1990583 | Molecular function | phospholipase D activator activity |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | ARF4 |
| Protein name | ADP-ribosylation factor 4 ADP ribosylation factor 4 |
| Synonyms | ARF2 |
| Description | FUNCTION: GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus. Part of the ciliary targeting complex containing Rab11, ASAP1, Rabin8/RAB3IP, RAB11FIP3 and ARF4, which direct preciliary vesicle trafficking to mother centriole and ciliogenesis initiation . . |
| Accessions | ENST00000463880.1 C9JAK5 C9JPM4 ENST00000488156.1 F8WDB3 U3KQF2 ENST00000489843.1 ENST00000303436.11 ENST00000486310.5 P18085 ENST00000496292.5 C9J6P1 |